Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,147
archived clinical trials in
Asthma

Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated:  5/9/2016
Clinical Research Facility
mi
from
Hopewell, VA
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated: 5/9/2016
Clinical Research Facility
mi
from
Hopewell, VA
Click here to add this to my saved trials
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated:  5/9/2016
Clinical Research Facility
mi
from
Greenfield, WI
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated: 5/9/2016
Clinical Research Facility
mi
from
Greenfield, WI
Click here to add this to my saved trials
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated:  5/9/2016
Clinical Research Facility
mi
from
Hartford, CT
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated: 5/9/2016
Clinical Research Facility
mi
from
Hartford, CT
Click here to add this to my saved trials
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated:  5/9/2016
Clinical Research Facility
mi
from
Cutler Bay, FL
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated: 5/9/2016
Clinical Research Facility
mi
from
Cutler Bay, FL
Click here to add this to my saved trials
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated:  5/9/2016
Clinical Research Facility
mi
from
St Petersburg, FL
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated: 5/9/2016
Clinical Research Facility
mi
from
St Petersburg, FL
Click here to add this to my saved trials
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated:  5/9/2016
Clinical Research Facility
mi
from
Louisville, KY
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated: 5/9/2016
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated:  5/9/2016
Clinical Research Facility
mi
from
Union, NJ
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated: 5/9/2016
Clinical Research Facility
mi
from
Union, NJ
Click here to add this to my saved trials
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated:  5/9/2016
Clinical Research Facility
mi
from
Hodges, SC
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated: 5/9/2016
Clinical Research Facility
mi
from
Hodges, SC
Click here to add this to my saved trials
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated:  5/9/2016
Clinical Research Facility
mi
from
McAllen, TX
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated: 5/9/2016
Clinical Research Facility
mi
from
McAllen, TX
Click here to add this to my saved trials
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated:  5/9/2016
Site Reference ID/Investigator# 22507
mi
from
Bedford Park,
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated: 5/9/2016
Site Reference ID/Investigator# 22507
mi
from
Bedford Park,
Click here to add this to my saved trials
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated:  5/9/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated: 5/9/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated:  5/9/2016
Clinical Research Facility
mi
from
North Dartmouth, MA
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated: 5/9/2016
Clinical Research Facility
mi
from
North Dartmouth, MA
Click here to add this to my saved trials
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated:  5/9/2016
Clinical Research Facility
mi
from
Quincy, MA
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated: 5/9/2016
Clinical Research Facility
mi
from
Quincy, MA
Click here to add this to my saved trials
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated:  5/9/2016
Clinical Research Facility
mi
from
Port Huron, MI
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated: 5/9/2016
Clinical Research Facility
mi
from
Port Huron, MI
Click here to add this to my saved trials
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated:  5/9/2016
Clinical Research Facility
mi
from
Morgantown, WV
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
A Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients With Uncontrolled Asthma
Status: Enrolling
Updated: 5/9/2016
Clinical Research Facility
mi
from
Morgantown, WV
Click here to add this to my saved trials
Immunotherapy Administered Under the Tongue to Treat Dust Mite Allergy
Sublingual Immunotherapy in Dust Mite Allergy
Status: Enrolling
Updated:  5/12/2016
University of Wisconsin Medical School
mi
from
Madison, WI
Immunotherapy Administered Under the Tongue to Treat Dust Mite Allergy
Sublingual Immunotherapy in Dust Mite Allergy
Status: Enrolling
Updated: 5/12/2016
University of Wisconsin Medical School
mi
from
Madison, WI
Click here to add this to my saved trials
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated:  6/1/2016
Novartis Investigative Site
mi
from
Avondale, AZ
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated: 6/1/2016
Novartis Investigative Site
mi
from
Avondale, AZ
Click here to add this to my saved trials
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated:  6/1/2016
Novartis Investigational Site
mi
from
Glendale, AZ
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated: 6/1/2016
Novartis Investigational Site
mi
from
Glendale, AZ
Click here to add this to my saved trials
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated:  6/1/2016
Novartis Investigational Site
mi
from
Glendale, AZ
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated: 6/1/2016
Novartis Investigational Site
mi
from
Glendale, AZ
Click here to add this to my saved trials
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated:  6/1/2016
Novartis Investigative Site
mi
from
Phoenix, AZ
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated: 6/1/2016
Novartis Investigative Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated:  6/1/2016
Novartis Investigative Site
mi
from
Phoenix, AZ
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated: 6/1/2016
Novartis Investigative Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated:  6/1/2016
Novartis Investigative Site
mi
from
Scottsdale, AZ
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated: 6/1/2016
Novartis Investigative Site
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated:  6/1/2016
Novartis Investigative Site
mi
from
Tucson, AZ
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated: 6/1/2016
Novartis Investigative Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated:  6/1/2016
Novartis Investigative Site
mi
from
Tucson, AZ
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated: 6/1/2016
Novartis Investigative Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated:  6/1/2016
Novartis Investigative Site
mi
from
Fair Oaks, CA
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated: 6/1/2016
Novartis Investigative Site
mi
from
Fair Oaks, CA
Click here to add this to my saved trials
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated:  6/1/2016
Novartis Investigative Site
mi
from
Hawaiian Gardens, CA
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated: 6/1/2016
Novartis Investigative Site
mi
from
Hawaiian Gardens, CA
Click here to add this to my saved trials
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated:  6/1/2016
Novartis Investigative Site
mi
from
Long Beach, CA
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated: 6/1/2016
Novartis Investigative Site
mi
from
Long Beach, CA
Click here to add this to my saved trials
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated:  6/1/2016
Novartis Investigative Site
mi
from
Madera, CA
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated: 6/1/2016
Novartis Investigative Site
mi
from
Madera, CA
Click here to add this to my saved trials
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated:  6/1/2016
Novartis Investigative Site
mi
from
North Hollywood, CA
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated: 6/1/2016
Novartis Investigative Site
mi
from
North Hollywood, CA
Click here to add this to my saved trials
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated:  6/1/2016
Novartis Investigative Site
mi
from
Palmdale, CA
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated: 6/1/2016
Novartis Investigative Site
mi
from
Palmdale, CA
Click here to add this to my saved trials
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated:  6/1/2016
Novartis Investigative Site
mi
from
San Diego, CA
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated: 6/1/2016
Novartis Investigative Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated:  6/1/2016
Novartis Investigative Site
mi
from
Centennial, CO
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated: 6/1/2016
Novartis Investigative Site
mi
from
Centennial, CO
Click here to add this to my saved trials
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated:  6/1/2016
Novartis Investigative Site
mi
from
Colorado Springs, CO
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated: 6/1/2016
Novartis Investigative Site
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated:  6/1/2016
Novartis
mi
from
Denver, CO
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated: 6/1/2016
Novartis
mi
from
Denver, CO
Click here to add this to my saved trials
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated:  6/1/2016
Novartis Investigative Site
mi
from
Bridgeport, CT
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated: 6/1/2016
Novartis Investigative Site
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated:  6/1/2016
Novartis Investigative Site
mi
from
Hartford, CT
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated: 6/1/2016
Novartis Investigative Site
mi
from
Hartford, CT
Click here to add this to my saved trials
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated:  6/1/2016
Novartis Investigative Site
mi
from
Stamford, CT
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated: 6/1/2016
Novartis Investigative Site
mi
from
Stamford, CT
Click here to add this to my saved trials
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated:  6/1/2016
Novartis Investigative Site
mi
from
Bradenton, FL
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated: 6/1/2016
Novartis Investigative Site
mi
from
Bradenton, FL
Click here to add this to my saved trials
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated:  6/1/2016
Novartis Investigator Site
mi
from
Clearwater, FL
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated: 6/1/2016
Novartis Investigator Site
mi
from
Clearwater, FL
Click here to add this to my saved trials
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated:  6/1/2016
Novartis Investigative Site
mi
from
Fort Lauderdale, FL
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated: 6/1/2016
Novartis Investigative Site
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated:  6/1/2016
Novartis Investigative Site
mi
from
Hialeah, FL
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated: 6/1/2016
Novartis Investigative Site
mi
from
Hialeah, FL
Click here to add this to my saved trials
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated:  6/1/2016
Novartis Investigative Site
mi
from
Jacksonville, FL
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated: 6/1/2016
Novartis Investigative Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated:  6/1/2016
Novartis Investigative Site
mi
from
Jacksonville, FL
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated: 6/1/2016
Novartis Investigative Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated:  6/1/2016
Novartis Investigative Site
mi
from
Miami, FL
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated: 6/1/2016
Novartis Investigative Site
mi
from
Miami, FL
Click here to add this to my saved trials
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated:  6/1/2016
Novartis Investigative Site
mi
from
Miami, FL
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated: 6/1/2016
Novartis Investigative Site
mi
from
Miami, FL
Click here to add this to my saved trials
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated:  6/1/2016
Novartis Investigative Site
mi
from
Miami, FL
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated: 6/1/2016
Novartis Investigative Site
mi
from
Miami, FL
Click here to add this to my saved trials
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated:  6/1/2016
Novartis Investigative Site
mi
from
Miami, FL
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated: 6/1/2016
Novartis Investigative Site
mi
from
Miami, FL
Click here to add this to my saved trials
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated:  6/1/2016
Novartis Investigative Site
mi
from
Miami, FL
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated: 6/1/2016
Novartis Investigative Site
mi
from
Miami, FL
Click here to add this to my saved trials
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated:  6/1/2016
Novartis Investigative Site
mi
from
North Miami Beach, FL
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated: 6/1/2016
Novartis Investigative Site
mi
from
North Miami Beach, FL
Click here to add this to my saved trials
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated:  6/1/2016
Novartis Investigative Site
mi
from
Orlando, FL
Study of Safety of Foradil in Patients With Persistent Asthma
A 26 Week, Randomized, Active-controlled Safety Study of Double-blind Formoterol Fumarate in Free Combination With an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients With Persistent Asthma.
Status: Enrolling
Updated: 6/1/2016
Novartis Investigative Site
mi
from
Orlando, FL
Click here to add this to my saved trials